X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-13 | JNJ | Broadhurst Vanessa | EVP, Global Corp Affairs | S - Sale | $162.16 | -8,891 | 15,043 | -37% | -$1,441,765 | ||||||
| D | 2024-02-09 | JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | S - Sale+OE | $156.27 | -59,397 | 141,416 | -30% | -$9,281,969 | |||||
2023-07-25 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $170.33 | -20,000 | 102,696 | -16% | -$3,406,498 | ||||||
| D | 2023-07-26 | JNJ | Hait William | See Remarks | S - Sale+OE | $172.00 | -14,698 | 87,747 | -14% | -$2,528,056 | |||||
2023-06-12 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Officer | S - Sale | $160.00 | -12,465 | 66,274 | -16% | -$1,994,400 | ||||||
2023-03-06 | JNJ | Swanson James D. | See Remarks | S - Sale | $154.66 | -1,062 | 9,215 | -10% | -$164,199 | ||||||
| D | 2022-12-13 | JNJ | Wolk Joseph J | EVP, CFO | S - Sale+OE | $179.60 | -14,781 | 37,800 | -28% | -$2,654,661 | |||||
| D | 2022-11-30 | JNJ | McEvoy Ashley | EVP, WW Chair, MedTech | S - Sale+OE | $175.47 | -73,323 | 44,808 | -62% | -$12,865,801 | |||||
| D | 2022-11-22 | JNJ | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | S - Sale+OE | $176.78 | -76,923 | 126,456 | -38% | -$13,598,402 | |||||
| D | 2022-11-18 | JNJ | Decker Robert J | Controller, CAO | S - Sale+OE | $175.00 | -16,928 | 16,178 | -51% | -$2,962,400 | |||||
| D | 2022-11-09 | JNJ | Wengel Kathryn E | EVP, Chief GSC Officer | S - Sale+OE | $173.42 | -16,410 | 71,644 | -19% | -$2,845,773 | |||||
| D | 2022-11-04 | JNJ | Mongon Thibaut | EVP, WW Chair, Consumer | S - Sale+OE | $171.18 | -35,246 | 40,133 | -47% | -$6,033,305 | |||||
2022-10-24 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $171.36 | -29,275 | 114,676 | -20% | -$5,016,623 | ||||||
2022-10-24 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $171.19 | -20,851 | 143,951 | -13% | -$3,569,558 | ||||||
2022-10-24 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $171.22 | -12,998 | 164,802 | -7% | -$2,225,554 | ||||||
2022-10-24 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $171.14 | -8,256 | 179,900 | -4% | -$1,412,940 | ||||||
2022-10-24 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $171.13 | -4,263 | 184,856 | -2% | -$729,520 | ||||||
| D | 2022-10-24 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale+OE | $171.02 | -2,815 | 189,819 | -1% | -$481,429 | |||||
| D | 2022-10-24 | JNJ | Hait William | See Remarks | S - Sale+OE | $171.55 | -15,000 | 80,236 | -16% | -$2,573,220 | |||||
2022-10-19 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $164.50 | -22,864 | 114,676 | -17% | -$3,761,197 | ||||||
2022-10-19 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $164.50 | -29,946 | 136,240 | -18% | -$4,926,207 | ||||||
2022-10-19 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale | $164.50 | -13,703 | 167,486 | -8% | -$2,254,185 | ||||||
| D | 2022-10-19 | JNJ | Fasolo Peter | EVP, CHRO | S - Sale+OE | $164.50 | -3,613 | 181,189 | -2% | -$594,349 | |||||
| D | 2022-06-10 | JNJ | Wengel Kathryn E | EVP, Chief GSC Officer | S - Sale+OE | $173.00 | -40,000 | 71,642 | -36% | -$6,920,040 | |||||
| D | 2022-05-26 | JNJ | Decker Robert J | Controller, CAO | S - Sale+OE | $180.00 | -8,462 | 16,169 | -34% | -$1,523,160 | |||||
| D | 2022-04-21 | JNJ | Hait William | See Remarks | S - Sale+OE | $183.58 | -29,699 | 80,236 | -27% | -$5,452,053 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |